Cicero, A.F.G.; Fogacci, F.; Giovannini, M.; Grandi, E.; D’Addato, S.; Borghi, C.
Estimating the Prevalence and Characteristics of Patients Potentially Eligible for Lipoprotein(a)-Lowering Therapies in a Real-World Setting. Biomedicines 2023, 11, 3289.
https://doi.org/10.3390/biomedicines11123289
AMA Style
Cicero AFG, Fogacci F, Giovannini M, Grandi E, D’Addato S, Borghi C.
Estimating the Prevalence and Characteristics of Patients Potentially Eligible for Lipoprotein(a)-Lowering Therapies in a Real-World Setting. Biomedicines. 2023; 11(12):3289.
https://doi.org/10.3390/biomedicines11123289
Chicago/Turabian Style
Cicero, Arrigo F. G., Federica Fogacci, Marina Giovannini, Elisa Grandi, Sergio D’Addato, and Claudio Borghi.
2023. "Estimating the Prevalence and Characteristics of Patients Potentially Eligible for Lipoprotein(a)-Lowering Therapies in a Real-World Setting" Biomedicines 11, no. 12: 3289.
https://doi.org/10.3390/biomedicines11123289
APA Style
Cicero, A. F. G., Fogacci, F., Giovannini, M., Grandi, E., D’Addato, S., & Borghi, C.
(2023). Estimating the Prevalence and Characteristics of Patients Potentially Eligible for Lipoprotein(a)-Lowering Therapies in a Real-World Setting. Biomedicines, 11(12), 3289.
https://doi.org/10.3390/biomedicines11123289
